SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Kun-Han Lue, Hsin-Hon Lin, Chih-Hao K. Kao, Hung-Jen Hsieh, Shu-Hsin Liu, Keh-Shih Chuang, A simple algorithm for subregional striatal uptake analysis with partial volume correction in dopaminergic PET imaging, Annals of Nuclear Medicine, 2014, 28, 1, 33

    CrossRef

  2. 2
    Marios Politis, Neuroimaging in Parkinson disease: from research setting to clinical practice, Nature Reviews Neurology, 2014, 10, 12, 708

    CrossRef

  3. 3
    Fabrizio Stocchi, Therapy for Parkinson’s Disease: What is in the Pipeline?, Neurotherapeutics, 2014, 11, 1, 24

    CrossRef

  4. 4
    Huajun Jin, Arthi Kanthasamy, Vellareddy Anantharam, Anumantha G. Kanthasamy, Biomarkers in Toxicology, 2014,

    CrossRef

  5. 5
    Pankaj A. Agarwal, A. Jon Stoessl, Biomarkers for trials of neuroprotection in Parkinson's disease, Movement Disorders, 2013, 28, 1
  6. 6
    Shichun Peng, Doris J. Doudet, Vijay Dhawan, Yilong Ma, Dopamine, PET Clinics, 2013, 8, 4, 469

    CrossRef

  7. You have free access to this content7
    A. Berardelli, G. K. Wenning, A. Antonini, D. Berg, B. R. Bloem, V. Bonifati, D. Brooks, D. J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.-P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, M. Vidailhet, EFNS/MDS-ES recommendations for the diagnosis of Parkinson's disease, European Journal of Neurology, 2013, 20, 1
  8. 8
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson’s Disease, 2013,

    CrossRef

  9. 9
    Joseph Jankovic, Raja Mehanna, Handbook of Parkinson's Disease, Fifth Edition, 2013,

    CrossRef

  10. 10
    Marios Politis, Paola Piccini, Positron emission tomography imaging in neurological disorders, Journal of Neurology, 2012, 259, 9, 1769

    CrossRef

  11. 11
    Raúl de la Fuente-Fernández, Michael Schulzer, Lisa Kuramoto, Jacquelyn Cragg, Nandhagopal Ramachandiran, Wing L. Au, Edwin Mak, Jess McKenzie, Siobhan McCormick, Vesna Sossi, Thomas J. Ruth, Chong S. Lee, Donald B. Calne, A. Jon Stoessl, Age-specific progression of nigrostriatal dysfunction in Parkinson's disease, Annals of Neurology, 2011, 69, 5
  12. 12
    Raúl de la Fuente-Fernández, Silke Appel-Cresswell, Doris J Doudet, Vesna Sossi, Functional neuroimaging in Parkinson's disease, Expert Opinion on Medical Diagnostics, 2011, 5, 2, 109

    CrossRef

  13. 13
    A. Jon Stoessl, David J. Brooks, David Eidelberg, Milestones in neuroimaging, Movement Disorders, 2011, 26, 6
  14. 14
    Jan Booij, Henk W. Berendse, Monitoring therapeutic effects in Parkinson's disease by serial imaging of the nigrostriatal dopaminergic pathway, Journal of the Neurological Sciences, 2011, 310, 1-2, 40

    CrossRef

  15. 15
    Ruth Djaldetti, Mordechai Lorberboym, Yuval Karmon, Therese A. Treves, Ilan Ziv, Eldad Melamed, Residual striatal dopaminergic nerve terminals in very long-standing Parkinson's disease: A single photon emission computed tomography imaging study, Movement Disorders, 2011, 26, 2
  16. 16
    Alex Iranzo, Francesc Valldeoriola, Francisco Lomeña, José Luis Molinuevo, Mónica Serradell, Manel Salamero, Albert Cot, Domènec Ros, Javier Pavía, Joan Santamaria, Eduardo Tolosa, Serial dopamine transporter imaging of nigrostriatal function in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study, The Lancet Neurology, 2011, 10, 9, 797

    CrossRef

  17. 17
    Sayaka Asari, Ken-ichi Fujimoto, Akihiro Miyauchi, Toshihiko Sato, Imaharu Nakano, Shin-ichi Muramatsu, Subregional 6-[18F]fluoro-ʟ-m-tyrosine Uptake in the Striatum in Parkinson's Disease, BMC Neurology, 2011, 11, 1, 35

    CrossRef

  18. 18
    Stanley Fahn, Joseph Jankovic, Mark Hallett, Principles and Practice of Movement Disorders, 2011,

    CrossRef

  19. 19
    SHIN-ICHI MURAMATSU, SAYAKA ASARI, KEN-ICHI FUJIMOTO, KEIYA OZAWA, IMAHARU NAKANO, GENE THERAPY FOR PARKINSON'S DISEASE: STRATEGIES FOR THE LOCAL PRODUCTION OF DOPAMINE, Gene Therapy and Regulation, 2010, 05, 01, 57

    CrossRef

  20. 20
    Hidemoto Saiki, Takuya Hayashi, Ryosuke Takahashi, Jun Takahashi, Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease, Journal of Neuroscience Methods, 2010, 190, 2, 198

    CrossRef

  21. 21
    Chrissa Sioka, Andreas Fotopoulos, Athanassios P. Kyritsis, Recent advances in PET imaging for evaluation of Parkinson’s disease, European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37, 8, 1594

    CrossRef

  22. 22
    Renju Kuriakose, A. Jon Stoessl, Recent Advances in Parkinson’S Disease - Translational and Clinical Research, 2010,

    CrossRef

  23. 23
    Limin Liu, Yong Wang, Bo Li, Jun Jia, Zuoli Sun, Jinming Zhang, Jiahe Tian, Xiaomin Wang, Evaluation of nigrostriatal damage and its change over weeks in a rat model of Parkinson's disease: small animal positron emission tomography studies with [11C]β-CFT, Nuclear Medicine and Biology, 2009, 36, 8, 941

    CrossRef

  24. 24
    Kurt A. Jellinger, Formation and development of Lewy pathology: a critical update, Journal of Neurology, 2009, 256, S3, 270

    CrossRef

  25. 25
    Juha O Rinne, Positron Emission Tomography in the Differential Diagnosis of Parkinsonism, Journal of Movement Disorders, 2009, 2, 2, 53

    CrossRef

  26. 26
    Walter Maetzler, Inga Liepelt, Daniela Berg, Progression of Parkinson's disease in the clinical phase: potential markers, The Lancet Neurology, 2009, 8, 12, 1158

    CrossRef